| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.091 | 0.1 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |